Exam Overview
Amniocentesis involves the collection and analysis of an
amniotic fluid sample.
Before an amniocentesis (and often during the entire procedure), a
fetal
ultrasound test is done to locate the fetus, the
placenta, and a large pocket of amniotic fluid. A
long, thin needle is inserted through the abdomen into the uterus, avoiding the
fetus and placenta, and a small amount [1 to
2 Tbsp (29.57 mL)] of amniotic
fluid is collected through the needle.
See an illustration of an
amniocentesis
.
Amniotic fluid contains cells that have been shed by the developing
fetus. These can be examined for chromosomal defects that cause conditions such
as
Down syndrome and
cystic fibrosis. Amniotic fluid can also be used to
identify the sex of the fetus.
Rh disease
Amniotic fluid can be tested for a fetus's
Rh factor. (Samples from the mother's and father's
blood are tested and compared.) If the fetus is Rh-negative, no further testing
or treatment is necessary during the current pregnancy.
Chemicals in the amniotic fluid can show whether an Rh-positive
fetus is being harmed by the mother's
antibodies to the Rh factor.
Bilirubin is naturally found in amniotic fluid. During
a normal pregnancy, the bilirubin level increases until 23 to 25 weeks of
pregnancy, and then decreases throughout the remainder of the pregnancy. If
fetal blood cells are being attacked by the mother's
immune system, the bilirubin level continues to
increase throughout the pregnancy. After the 20th week of pregnancy, bilirubin
measurements are accurate enough to guide further testing or treatment.
Fetal lung maturity
The chemicals lecithin and sphingomyelin are produced by the
fetus's lungs and are found in the amniotic fluid. Their amounts are measured
and their levels are compared as a ratio (L/S ratio). This number gives an
indication of fetal lung maturity and ability to breathe independently if an
early (preterm) delivery is necessary.
Another estimate of fetal maturity is the amount of
phosphatidylglycerol (PG) in the amniotic fluid. This test is usually done
during the same amniocentesis but is determined prior to the L/S ratios,
especially for pregnant women who have
diabetes. When tested in a diabetic woman, the L/S
ratio is more likely to show that the fetus's lungs are mature when they are
not.
Why It Is Done
Amniocentesis may be done to:
- Learn the fetal
blood type and Rh factor. An Rh-negative fetus is not
at risk, even if the mother is Rh-sensitized.
- Check fetal health
when the mother is
sensitized to the Rh factor. (Doppler
ultrasound can give you the same information without the risks of
amniocentesis.1)
- Learn whether and when
fetal blood sampling is needed.
- Learn whether fetal lungs are
mature if the fetus needs to be delivered earlier than 37 weeks (preterm
birth).
Results
When maternal Rh antibody levels are too high, an amniocentesis may
be done. The amount of bilirubin found in the amniotic fluid is used to predict
the level of fetal harm that is occurring from Rh sensitization.
- Amniocentesis is repeated every 2 to 4 weeks if
the fetus is mildly affected. The fetus is usually delivered close to
term.
- Amniocentesis is repeated every 1 to 2 weeks if the fetus is
being moderately affected. The fetus is usually delivered earlier than 38 weeks
and may need a
blood transfusion after
birth.
- Amniocentesis may be repeated every week if the fetus is
being severely affected. The fetus may need a blood transfusion before birth
and is usually delivered early.
The results of amniocentesis may guide treatment for Rh
sensitization. The level of fetal lung maturity that is shown by the L/S ratio
may help plan the timing of delivery.
- If the bilirubin levels are very high but the
fetus is less than 32 weeks'
gestation, a blood transfusion before birth may be
done to keep the fetus healthy until delivery is possible.
- If
bilirubin levels are very high, and the fetus is older than 32 weeks' gestation
but the fetus's lungs are still immature, medication may be given to speed up
fetal lung development. Delivery is ideally done 2 days later.
- If
fetal lungs appear to be mature, then delivery does not need to be delayed.
What To Think About
Amniocentesis carries a slight risk of injuring the fetus, starting
labor, or introducing an infection into the uterus.
When amniocentesis is done by a highly trained provider, the risk
for
miscarriage may be as low as 1 in 400, according to
one study.2 Some studies have shown higher risks,
between 2 and 4 in 400.3
For checking anemia in a fetus,
Doppler ultrasound can give you the same information
as amniocentesis, without the risks.1
Amniocentesis is less sensitive than fetal blood sampling (FBS).
However, because it is less risky than FBS, amniocentesis is the preferred test
for detecting mild to moderate Rh disease.
Normal results from amniocentesis do not guarantee that the baby
will be healthy.
Amniocentesis may cause mixing of the mother's and fetus's blood.
Therefore, unsensitized Rh-negative women are given Rh immune globulin after
amniocentesis to prevent
sensitization.
Complete the
medical test information form (PDF)
(What is a PDF document?)
to help you prepare for this test.